The DOI matches its Crossref record; 124 of the 124 references it cites were found in a registry or an index.
Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
Open accessAbstract
Proton pump inhibitors (PPIs) potently inhibit gastric acid secretion and are widely used for treatment of acid-related diseases including gastroesophageal reflux disease and secondary prevention of aspirin/NSAID-induced ulcers. Although clinically important adverse effects of PPIs can occur, just as with other drugs, those are not frequently observed during or after administration. Thus, PPIs are regarded as relatively safe and considered to be clinically beneficial. Recently, PPIs have become frequently administered to patients with functional gastrointestinal diseases or primary prevention of drug-related gastroduodenal damage, even though their beneficial effects for those conditions have not been fully confirmed. PPIs tend to be given for conditions in which the necessity of the drug has not been clarified, thus otherwise rare adverse effects are presented as clinically relevant. Although several PPI-related adverse effects have been reported, their clinical relevance is not yet clear, since the evidence reported in those studies is not at a high enough level, as the majority are based on retrospective observational studies and the reported hazard ratios are low. It is important to administer PPIs only for patients who will gain a substantial clinical benefit and to continue to investigate their adverse effects with high quality prospective studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lundell, L. R., Dent, J., Bennett, J. R., Blum, A. L., Armstrong, D., Galmiche, J. P., Johnson, F., Hongo, M., Richter, J. E., Spechler, S. J., et al. (1999) · Gut · doi:10.1136/gut.45.2.172 · Cited by 2,305
Proton pump inhibitors affect the gut microbiome
Imhann, F., Bonder, M. J., Vich Vila, A., Fu, J., Mujagic, Z., Vork, L., Tigchelaar, E. F., Jankipersadsing, S. A., Cenit, M. C., Harmsen, H. J. M., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310376 · Cited by 1,371
Clopidogrel with or without Omeprazole in Coronary Artery Disease
Bhatt, D. L., Cryer, B. L., Contant, C. F., Cohen, M., Lanas, A., Schnitzer, T. J., Shook, T. L., Lapuerta, P., Goldsmith, M. A., Laine, L., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1007964 · Cited by 1,240
Ho, P. M. (2009) · JAMA · doi:10.1001/jama.2009.261 · Cited by 1,007
Proton pump inhibitors alter the composition of the gut microbiota
Jackson, M. A., Goodrich, J. K., Maxan, M.-E., Freedberg, D. E., Abrams, J. A., Poole, A. C., Sutter, J. L., Welter, D., Ley, R. E., Bell, J. T., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310861 · Cited by 895
Freedberg, D. E., Kim, L. S., & Yang, Y.-X. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.01.031 · Cited by 891
Risk of Community-Acquired Pneumonia and Use of Gastric Acid–Suppressive Drugs
Laheij, R. J. F. (2004) · JAMA · doi:10.1001/jama.292.16.1955 · Cited by 877
Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
Hawkey, C. J., Karrasch, J. A., Szczepañski, L., Walker, D. G., Barkun, A., Swannell, A. J., & Yeomans, N. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381105 · Cited by 863
Kuipers, E. J., Lundell, L., Klinkenberg-Knol, E. C., Havu, N., Festen, H. P. M., Liedman, B., Lamers, C. B. H. W., Jansen, J. B. M. J., Dalenbäck, J., Snel, P., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604183341603 · Cited by 769
Yeomans, N. D., Tulassay, Z., Juhász, L., Rácz, I., Howard, J. M., van Rensburg, C. J., Swannell, A. J., & Hawkey, C. J. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381104 · Cited by 767
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Lazarus, B., Chen, Y., Wilson, F. P., Sang, Y., Chang, A. R., Coresh, J., & Grams, M. E. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2015.7193 · Cited by 729
O'Donoghue, M. L., Braunwald, E., Antman, E. M., Murphy, S. A., Bates, E. R., Rozenman, Y., Michelson, A. D., Hautvast, R. W., Ver Lee, P. N., Close, S. L., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61525-7 · Cited by 725
Proton Pump Inhibitor and Histamine 2 Receptor Antagonist Use and Vitamin B12Deficiency
Lam, J. R., Schneider, J. L., Zhao, W., & Corley, D. A. (2013) · JAMA · doi:10.1001/jama.2013.280490 · Cited by 582
Gomm, W., von Holt, K., Thomé, F., Broich, K., Maier, W., Fink, A., Doblhammer, G., & Haenisch, B. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2015.4791 · Cited by 563
Murakami, K., Sakurai, Y., Shiino, M., Funao, N., Nishimura, A., & Asaka, M. (2016) · Gut · doi:10.1136/gutjnl-2015-311304 · Cited by 484
Complications of Proton Pump Inhibitor Therapy
Vaezi, M. F., Yang, Y.-X., & Howden, C. W. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.04.047 · Cited by 482
Bavishi, C., & DuPont, H. L. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04874.x · Cited by 480
Cheung, K. S., Chan, E. W., Wong, A. Y. S., Chen, L., Wong, I. C. K., & Leung, W. K. (2018) · Gut · doi:10.1136/gutjnl-2017-314605 · Cited by 455
A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole
Olbe, L., Carlsson, E., & Lindberg, P. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1010 · Cited by 418
Proton Pump Inhibitor Use and the Risk of Small Intestinal Bacterial Overgrowth: A Meta-analysis
Lo, W., & Chan, W. W. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.12.011 · Cited by 353
Gulmez, S. E. (2007) · Archives of Internal Medicine · doi:10.1001/archinte.167.9.950 · Cited by 341
Biopsy-proven acute interstitial nephritis, 1993-2011: a case series
Muriithi, A. K., Leung, N., Valeri, A. M., Cornell, L. D., Sethi, S., Fidler, M. E., & Nasr, S. H. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.04.027 · Cited by 337
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD
Xie, Y., Bowe, B., Li, T., Xian, H., Balasubramanian, S., & Al-Aly, Z. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015121377 · Cited by 337
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
Shah, N. H., LePendu, P., Bauer-Mehren, A., Ghebremariam, Y. T., Iyer, S. V., Marcus, J., Nead, K. T., Cooke, J. P., & Leeper, N. J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0124653 · Cited by 335
Gray, S. L. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.94 · Cited by 329
Proton-Pump Inhibitor Use and the Risk for Community-Acquired Pneumonia
Sarkar, M., Hennessy, S., & Yang, Y.-X. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-6-200809160-00005 · Cited by 301
Singh, S., Garg, S. K., Singh, P. P., Iyer, P. G., & El-Serag, H. B. (2014) · Gut · doi:10.1136/gutjnl-2013-305997 · Cited by 298
Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015
Iwakiri, K., Kinoshita, Y., Habu, Y., Oshima, T., Manabe, N., Fujiwara, Y., Nagahara, A., Kawamura, O., Iwakiri, R., Ozawa, S., et al. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-016-1227-8 · Cited by 285
Self-citationNgamruengphong, S., Leontiadis, G. I., Radhi, S., Dentino, A., & Nugent, K. (2011) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.113 · Cited by 281
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection
Linsky, A. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.73 · Cited by 276
Corley, D. A., Kubo, A., Zhao, W., & Quesenberry, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.03.055 · Cited by 271
Increased risk of fundic gland polyps during long‐term proton pump inhibitor therapy
JALVING, M., KOORNSTRA, J. J., WESSELING, J., BOEZEN, H. M., DE JONG, S., & KLEIBEUKER, J. H. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03127.x · Cited by 269
Lundell, L., Vieth, M., Gibson, F., Nagy, P., & Kahrilas, P. J. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13324 · Cited by 258 · cited 2×
“pylori, the administration of PPIs has been repeatedly reported to augment mucosal inflammation and accelerate mucosal atrophy, which may increase the risk of gastric cancer, although some diversities in study results are found.(91,135,136) Furthermore, some observational studies have suggested that PPIs increase gast…”
BackgroundResultTargownik, L. E., Lix, L. M., Leung, S., & Leslie, W. D. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.11.014 · Cited by 253
Laine, Ahnen, Mcclain, Solcia, & Walsh (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00768.x · Cited by 247
Risk of dementia in elderly patients with the use of proton pump inhibitors
Haenisch, B., von Holt, K., Wiese, B., Prokein, J., Lange, C., Ernst, A., Brettschneider, C., König, H.-H., Werle, J., Weyerer, S., et al. (2015) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-014-0554-0 · Cited by 244
Xie, Y., Bowe, B., Li, T., Xian, H., Yan, Y., & Al-Aly, Z. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015735 · Cited by 234
A Case Series of Proton Pump Inhibitor–Induced Hypomagnesemia
Hoorn, E. J., van der Hoek, J., de Man, R. A., Kuipers, E. J., Bolwerk, C., & Zietse, R. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.11.019 · Cited by 233
Review article: proton pump inhibitors and bacterial overgrowth
WILLIAMS, C., & McCOLL, K. E. L. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.02707.x · Cited by 221
Shirai, N., Furuta, T., Moriyama, Y., Okochi, H., Kobayashi, K., Takashima, M., Xiao, F., Kosuge, K., Nakagawa, K., Hanai, H., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.01108.x · Cited by 221
Cheungpasitporn, W., Thongprayoon, C., Kittanamongkolchai, W., Srivali, N., Edmonds, P. J., Ungprasert, P., O'Corragain, O. A., Korpaisarn, S., & Erickson, S. B. (2015) · Renal Failure · doi:10.3109/0886022x.2015.1057800 · Cited by 215
Acid-Suppressive Medications and Risk of Bone Loss and Fracture in Older Adults
Yu, E. W., Blackwell, T., Ensrud, K. E., Hillier, T. A., Lane, N. E., Orwoll, E., & Bauer, D. C. (2008) · Calcified Tissue International · doi:10.1007/s00223-008-9170-1 · Cited by 210
Tran-Duy, A., Spaetgens, B., Hoes, A. W., de Wit, N. J., & Stehouwer, C. D. A. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2016.05.018 · Cited by 207
Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis
Hutchinson, C., Geissler, C. A., Powell, J. J., & Bomford, A. (2007) · Gut · doi:10.1136/gut.2006.108613 · Cited by 205
Brusselaers, N., Wahlin, K., Engstrand, L., & Lagergren, J. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017739 · Cited by 204
Dam, G., Vilstrup, H., Watson, H., & Jepsen, P. (2016) · Hepatology · doi:10.1002/hep.28737 · Cited by 190 · cited 1×
“Recently, in addition, PPI administration is also reported to be associated with hepatic encephalopathy in patients with cirrhosis.(70,148) The PPI-induced gut microbial changes or PPI-induced hypomagnesemia and vitamin B12 deficiency are considered to be possible links between hepatic encephalopathy and PPI administr…”
BackgroundGillen, D., Wirz, A. A., Ardill, J. E., & McColl, K. E. L. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70118-6 · Cited by 185
Nochaiwong, S., Ruengorn, C., Awiphan, R., Koyratkoson, K., Chaisai, C., Noppakun, K., Chongruksut, W., & Thavorn, K. (2018) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw470 · Cited by 185
Filion, K. B., Chateau, D., Targownik, L. E., Gershon, A., Durand, M., Tamim, H., Teare, G. F., Ravani, P., Ernst, P., Dormuth, C. R., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-304738 · Cited by 183
Proton Pump Inhibitor Use and Risk of Hip Fractures in Patients without Major Risk Factors
Kaye, J. A., & Jick, H. (2008) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.8.951 · Cited by 182
Tsai, C.-F., Chen, M.-H., Wang, Y.-P., Chu, C.-J., Huang, Y.-H., Lin, H.-C., Hou, M.-C., Lee, F.-Y., Su, T.-P., & Lu, C.-L. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.007 · Cited by 175
The Proton-Pump Inhibitor Lansoprazole Enhances Amyloid Beta Production
Badiola, N., Alcalde, V., Pujol, A., Münter, L.-M., Multhaup, G., Lleó, A., Coma, M., Soler-López, M., & Aloy, P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058837 · Cited by 165
Meta‐analysis: proton pump inhibitor use and the risk of community‐acquired pneumonia
JOHNSTONE, J., NERENBERG, K., & LOEB, M. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04284.x · Cited by 163
Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease
Klatte, D. C. F., Gasparini, A., Xu, H., de Deco, P., Trevisan, M., Johansson, A. L. V., Wettermark, B., Ärnlöv, J., Janmaat, C. J., Lindholm, B., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.05.046 · Cited by 163
Simon, T., Steg, P. G., Gilard, M., Blanchard, D., Bonello, L., Hanssen, M., Lardoux, H., Coste, P., Lefèvre, T., Drouet, E., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.965640 · Cited by 159
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study
Poulsen, A. H., Christensen, S., McLaughlin, J. K., Thomsen, R. W., Sørensen, H. T., Olsen, J. H., & Friis, S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605024 · Cited by 158
Do proton pump inhibitors decrease calcium absorption?
Hansen, K. E., Jones, A. N., Lindstrom, M. J., Davis, L. A., Ziegler, T. E., Penniston, K. L., Alvig, A. L., & Shafer, M. M. (2010) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.166 · Cited by 150
Proton Pump Inhibitors and Risk of Mild Cognitive Impairment and Dementia
Goldstein, F. C., Steenland, K., Zhao, L., Wharton, W., Levey, A. I., & Hajjar, I. M. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14956 · Cited by 147
CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole
Adachi, K., Katsube, T., Kawamura, A., et al. (2000) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2000.00840.x · Cited by 144
Keszthelyi, D., Jansen, S. V., Schouten, G. A., de Kort, S., Scholtes, B., Engels, L. G. J. B., & Masclee, A. (2010) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2010.04453.x · Cited by 142
Attwood, S., Ell, C., Galmiche, J. P., Fiocca, R., Hatlebakk, J. G., Hasselgren, B., Långström, G., Jahreskog, M., Eklund, S., Lind, T., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13194 · Cited by 141
Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case–Control Study
Robertson, D. J., Larsson, H., Friis, S., Pedersen, L., Baron, J. A., & Sørensen, H. T. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.014 · Cited by 139 · cited 1×
“Two large independent observational studies investigated the risk of colon cancer during chronic administration of PPIs, and both found no evidence of increased risk.(144,145) Therefore, PPIs are considered not to increase the risk of colon cancer despite their association with elevated plasma gastrin levels.”
BackgroundTargownik, L. E., Leslie, W. D., Davison, S. K., Goltzman, D., Jamal, S. A., Kreiger, N., Josse, R. G., Kaiser, S., Kovács, C. S., Prior, J. C., et al. (2012) · The American Journal of Gastroenterology · doi:10.1038/ajg.2012.200 · Cited by 134
Gastric Polyps Study Group, Hongo, M., & Fujimoto, K. (2010) · Journal of Gastroenterology · doi:10.1007/s00535-010-0207-7 · Cited by 129
Terg, R., Casciato, P. C., Garbe, C., Cartier, M., Stieben, T. E., Mendizábal, M., Niveyro, C., Benavides, J., Marino, M., Colombato, L., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.11.036 · Cited by 129
Chronic Proton Pump Inhibitor Therapy and the Risk of Colorectal Cancer
Yang, Y., Hennessy, S., Propert, K., Hwang, W., Sedarat, A., & Lewis, J. D. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.06.022 · Cited by 125 · cited 1×
“Two large independent observational studies investigated the risk of colon cancer during chronic administration of PPIs, and both found no evidence of increased risk.(144,145) Therefore, PPIs are considered not to increase the risk of colon cancer despite their association with elevated plasma gastrin levels.”
BackgroundPPIs and kidney disease: from AIN to CKD
Moledina, D. G., & Perazella, M. A. (2016) · Journal of Nephrology · doi:10.1007/s40620-016-0309-2 · Cited by 125
Proton pump inhibitors are associated with increased risk of development of chronic kidney disease
Arora, P., Gupta, A., Golzy, M., Patel, N., Carter, R. L., Jalal, K., & Lohr, J. W. (2016) · BMC Nephrology · doi:10.1186/s12882-016-0325-4 · Cited by 125
Melloni, C., Washam, J. B., Jones, W. S., Halim, S. A., Hasselblad, V., Mayer, S., Heidenfelder, B. L., & Dolor, R. J. (2015) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.114.001177 · Cited by 122
Serum Iron, Ferritin, and Vitamin B12 During Prolonged Omeprazole Therapy
Koop, H., & Bachem, M. G. (1992) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199206000-00005 · Cited by 119
The continuing development of proton pump inhibitors with particular reference to pantoprazole
Huber, R., KOHL, B., Sachs, G. M., Senn‐Bilfinger, J., Simon, W. A., & Sturm, E. (1995) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1995.tb00394.x · Cited by 117
We Are Using Too Many PPIs, and We Need to Stop: A European Perspective
Lanas, A. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.166 · Cited by 117
Proton Pump Inhibitors and Risk for Recurrent Clostridium difficile Infection Among Inpatients
Freedberg, D. E., Salmasian, H., Friedman, C., & Abrams, J. A. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.333 · Cited by 116
Hirschowitz, B. I., Worthington, J. L., & Mohnen, J. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03658.x · Cited by 115
Proton Pump Inhibitor Use and Dementia Risk: Prospective Population‐Based Study
Gray, S. L., Walker, R. L., Dublin, S., Yu, O., Bowles, E. J. A., Anderson, M. L., Crane, P. K., & Larson, E. B. (2017) · Journal of the American Geriatrics Society · doi:10.1111/jgs.15073 · Cited by 113
Stewart, Termanini, Sutliff, Serrano, Yu, Gibril, & Jensen (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00274.x · Cited by 112
Torpey, N., Barker, T., & Ross, C. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh137 · Cited by 112
The binding selectivity of vonoprazan ( TAK ‐438) to the gastric H + ,K + ‐ ATP ase
Scott, D. R., Munson, K. B., Marcus, E. A., Lambrecht, N. W. G., & Sachs, G. M. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13414 · Cited by 111
Oral microbiome alterations of healthy volunteers with proton pump inhibitor
Mishiro, T., Oka, K., Kuroki, Y., Takahashi, M., Tatsumi, K., Saitoh, T., Tobita, H., Ishimura, N., Sato, S., Ishihara, S., et al. (2018) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14040 · Cited by 96
Self-citationNo Association Between Proton Pump Inhibitor Use and Risk of Alzheimer’s Disease
Taipale, H. T., Tolppanen, A., Tiihonen, M., Tanskanen, A. J., Tiihonen, J., & Hartikainen, S. A. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.196 · Cited by 92
Association between proton pump inhibitor use and cognitive function in women
Lochhead, P., Hagan, K., Joshi, A. D., Khalili, H., Nguyen, L. H., Grodstein, F., & Chan, A. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.061 · Cited by 83
Sultan, N., Nazareno, J., & Gregor, J. C. (2008) · Canadian Journal of Gastroenterology · doi:10.1155/2008/821385 · Cited by 79
Sporadic Fundic Gland Polyposis: A Clinical, Histological, and Molecular Analysis
Torbenson, M. S., Lee, J.-H., Cruz-Correa, M. R., Ravich, W. J., Rastgar, K., Abraham, S. C., & Wu, T. (2002) · Modern Pathology · doi:10.1097/01.mp.0000018976.15044.9b · Cited by 79
Gastric Acidity, Atrophic Gastritis, and Calcium Absorption*
Wood, R. J., & Serfaty-Lacrosnière, C. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.1992.tb02510.x · Cited by 79
Brunner, G. H. G., Athmann, C., & Schneider, A. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05106.x · Cited by 76
Clinical Factors Associated With Development of Severe-Complicated Clostridium difficile Infection
Shivashankar, R., Khanna, S., Kammer, P. P., Harmsen, W. S., Zinsmeister, A. R., Baddour, L. M., & Pardi, D. S. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.04.050 · Cited by 75
The Zollinger–Ellison Syndrome: Dangers and Consequences of Interrupting Antisecretory Treatment
Poitras, P., Gingras, M., & Rehfeld, J. F. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.08.012 · Cited by 74
Yu, T., Tang, Y., Jiang, L., Zheng, Y., Xiong, W., & Lin, L. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.12.009 · Cited by 74
Faleck, D. M., Salmasian, H., Furuya, Y. E., Larson, E., Abrams, J. A., & Freedberg, D. E. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.343 · Cited by 74
Haga, Y., Nakatsura, T., Shibata, Y., Sameshima, H., Nakamura, Y., Tanimura, M., & Ogawa, M. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1018881617038 · Cited by 72
Sato, Y., Imamura, H., Kaizaki, Y., Koizumi, W., Ishido, K., Kurahara, K., Suzuki, H., Fujisaki, J., Hirakawa, K., Hosokawa, O., et al. (2013) · Digestive Endoscopy · doi:10.1111/den.12197 · Cited by 69
Vanclooster, A., van Deursen, C., Jaspers, R., Cassiman, D., & Koek, G. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.006 · Cited by 68 · cited 1×
“However, in cases with a deficient regulatory mechanism including hereditary hemochromatosis, decreased iron absorption may occur during long-term administration.(115,116) For absorption of calcium, gastric acid may have important roles.”
BackgroundChronic Proton Pump Inhibitor Therapy Associated with Increased Development of Fundic Gland Polyps
Ally, M., Veerappan, G. R., Maydonovitch, C. L., Duncan, T. J., Perry, J. L., Osgard, E. M., & Wong, R. K. H. (2009) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0993-z · Cited by 68
Colucci, R., Blandizzi, C., Tanini, M., Vassalle, C., Breschi, M. C., & Tacca, M. D. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706053 · Cited by 68
Gastric Acid Suppression and Outcomes in Clostridium difficile Infection: A Population-Based Study
Khanna, S., Aronson, S., Kammer, P. P., Baddour, L. M., & Pardi, D. S. (2012) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2011.12.021 · Cited by 68
Serbin, M., Guzauskas, G. F., & Veenstra, D. L. (2016) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2016.22.8.939 · Cited by 68
Wang, Y.-F., Chen, Y., Luo, J., Chen, T., Wu, J., & Wang, S. (2017) · The American Journal of Gastroenterology · doi:10.1038/ajg.2017.101 · Cited by 68
Reg protein is a unique growth factor of gastric mucosal cells
Kinoshita, Y., Ishihara, S., Kadowaki, Y., Fukui, H., & Chiba, T. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-004-1354-5 · Cited by 66
Self-citationSugano, K., Choi, M., Lin, J., Goto, S., Okada, Y., Kinoshita, Y., Miwa, H., Chiang, C., Chiba, T., Hori, M., et al. (2013) · Gut · doi:10.1136/gutjnl-2013-304722 · Cited by 60
Self-citationKomazawa, Y., Adachi, K., MIHARA, T., Ono, M., Kawamura, A., Fujishiro, H., & Kinoshita, Y. (2003) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2003.03041.x · Cited by 59
Self-citationBrophy, S. T., Jones, K. H., Rahman, M. A., Zhou, S., John, A. M., Atkinson, M. D., Francis, N. A., Lyons, R. A., & Dunstan, F. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.30 · Cited by 58
Lin, C., Wang, C., Hui, C. ‐. R., et al. (2017) · Allergy · doi:10.1111/all.13235 · Cited by 54
Inhibition of lysosomal enzyme activities by proton pump inhibitors
Liu, W., Baker, S. S., Trinidad, J. C., Burlingame, A. L., Baker, R. D., Forte, J. G., Virtuoso, L. P., Egilmez, N. K., & Zhu, L. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0774-5 · Cited by 53
Hokimoto, S., Mizobe, M., Akasaka, T., Arima, Y., Kaikita, K., Nakagawa, K., & Ogawa, H. (2014) · Thrombosis Research · doi:10.1016/j.thromres.2014.01.003 · Cited by 48
Campana, D., Ravizza, D., Ferollà, P., Faggiano, A., Grimaldi, F., Albertelli, M., Ricci, C., Santini, D., Brighi, N., Fazio, N., et al. (2016) · Endocrine · doi:10.1007/s12020-016-1099-y · Cited by 45
Kim, J. H., Lim, K. S., Min, Y. W., Lee, H., Min, B., Rhee, P., Kim, J. J., Koh, K. C., & Paik, S. W. (2016) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.13637 · Cited by 45
Capurso, G., Marignani, M., Attilia, F., Milione, M., Colarossi, C., Zampaletta, C., Giulio, E. D., & Fave, G. D. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.11.015 · Cited by 44
Khan, M. A., Kamal, S., Khan, S., Lee‐Smith, W., & Howden, C. W. (2015) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000448 · Cited by 43
Omeprazole‐induced acute interstitial nephritis: A possible Th 1– Th 17‐mediated injury?
Berney‐Meyer, L., Hung, N. A., Slatter, T. L., Schollum, J. B. W., Kitching, A. R., & Walker, R. J. (2014) · Nephrology · doi:10.1111/nep.12226 · Cited by 42
Occurrence of Community-Acquired Respiratory Tract Infection in Patients Receiving Esomeprazole
Estborn, L., & Joelson, S. (2008) · Drug Safety · doi:10.2165/00002018-200831070-00008 · Cited by 40
Pace, F., Annese, V., Prada, A., Zambelli, A., Casalini, S., Nardini, P., & Porro, G. B. (2005) · Digestive and Liver Disease · doi:10.1016/j.dld.2005.04.026 · Cited by 35
Funck‐Brentano, C., Szymezak, J., Steichen, O., Ducint, D., Molimard, M., Remones, V., Azizi, M., & Gaussem, P. (2013) · Archives of cardiovascular diseases · doi:10.1016/j.acvd.2013.09.002 · Cited by 33
Omeprazole in oesophageal reflux disease
Dawson, R., & Manson, J. (2000) · The Lancet · doi:10.1016/s0140-6736(05)71964-4 · Cited by 31
Fujisawa, T., Adachi, K., Komazawa, Y., MIHARA, T., Azumi, T., Katsube, T., Furuta, K., Kazumori, H., & Kinoshita, Y. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02147.x · Cited by 27
Self-citationSingh, M., Dhindsa, G., Friedland, S., & Triadafilopoulos, G. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03450.x · Cited by 26
The role of gastrin in colorectal carcinogenesis
Takhar, A. S., Eremin, O., & Watson, S. A. (2004) · The Surgeon · doi:10.1016/s1479-666x(04)80093-3 · Cited by 25
Early use of omeprazole benefits patients with acute myocardial infarction
Gao, Q., Sun, Y., Sun, Y.-X., Wang, L., & Fu, L. (2008) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-008-0282-2 · Cited by 24
Shimura, S., Hamamoto, N., Yoshino, N., Kushiyama, Y., Fujishiro, H., Komazawa, Y., Furuta, K., Ishihara, S., Adachi, K., & Kinoshita, Y. (2012) · Current Therapeutic Research · doi:10.1016/j.curtheres.2012.03.002 · Cited by 22
Self-citationClassification of gastric neuroendocrine tumors and its clinicopathologic significance
Yu, J., Wang, L., Meng, Y., Hu, M., Wang, J., & Bordi, C. (1998) · World Journal of Gastroenterology · doi:10.3748/wjg.v4.i2.158 · Cited by 21
Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users
Biyik, M., Solak, Y., Uçar, R., et al. (2014) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000154 · Cited by 20
Esomeprazole-induced rhabdomyolysis in a patient with heart failure
Tröger, U., Reiche, I., Jepsen, M. S., Huth, C., & Bode‐Böger, S. M. (2010) · Intensive Care Medicine · doi:10.1007/s00134-010-1854-0 · Cited by 18
Acid-suppressing therapies and subsite-specific risk of stomach cancer
Wennerström, C., Simonsen, J., Camargo, M. C., & Rabkin, C. S. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.84 · Cited by 17
Zaccardi, F., Pitocco, D., Martini, F., Caputo, S., Miele, L., Grieco, A., & Ghirlanda, G. (2012) · Acta Diabetologica · doi:10.1007/s00592-012-0382-5 · Cited by 6
Proton Pump Inhibitors and Chronic Kidney Disease: Causation or Another False Alarm?
Bjorkman, D. J. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.07.028 · Cited by 3
Metadata
- Authors
- Kinoshita, Y., Ishimura, N., & Ishihara, S.
- Venue
- Journal of Neurogastroenterology and Motility
- Published
- 2018-04-30
- Volume
- 24
- Issue
- 2
- Pages
- 182-196
- ISSN
- 2093-0879 (ISSN-L)
- 2093-0887
- OpenAlex
- W2802722762
- Cited by
- 271
- References
- 124
- FWCI
- 22.21
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.